Amplification Refractory Mutation System, a Highly Sensitive and Simple Polymerase Chain Reaction Assay, for the Detection of JAK2 V617F Mutation in Chronic Myeloproliferative Disorders

This publication has 18 references indexed in Scilit:

• JAK2 V617F in Myeloid Disorders: Molecular Diagnostic Techniques and Their Clinical Utility
  The Journal of Molecular Diagnostics, 2006
• Diagnostic Assays for the JAK2 V617F Mutation in Chronic Myeloproliferative Disorders
  American Journal of Clinical Pathology, 2006
• Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha
  Blood, 2006
• A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis
  Leukemia, 2006
• Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
  Leukemia, 2005
• Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
  Blood, 2005
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
  Published by Elsevier ,2005
• A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders
  New England Journal of Medicine, 2005
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005
• A Unique Activating Mutation in JAK2 (V617F) Is at the Origin of Polycythemia Vera and Allows a New Classification of Myeloproliferative Diseases
  Hematology-American Society Hematology Education Program, 2005